CA2205138A1 - Anticorps humains pour les peptides recepteurs de lymphocytes t et leur methode de preparation - Google Patents
Anticorps humains pour les peptides recepteurs de lymphocytes t et leur methode de preparationInfo
- Publication number
- CA2205138A1 CA2205138A1 CA002205138A CA2205138A CA2205138A1 CA 2205138 A1 CA2205138 A1 CA 2205138A1 CA 002205138 A CA002205138 A CA 002205138A CA 2205138 A CA2205138 A CA 2205138A CA 2205138 A1 CA2205138 A1 CA 2205138A1
- Authority
- CA
- Canada
- Prior art keywords
- antibodies
- human
- bind
- tcr
- antibody
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/06—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies from serum
- C07K16/065—Purification, fragmentation
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
- C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
- C07K16/2803—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against the immunoglobulin superfamily
- C07K16/2809—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against the immunoglobulin superfamily against the T-cell receptor (TcR)-CD3 complex
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Immunology (AREA)
- Organic Chemistry (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- General Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Molecular Biology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- Genetics & Genomics (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pain & Pain Management (AREA)
- Rheumatology (AREA)
- Peptides Or Proteins (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
Abstract
Préparations d'anticorps humains enrichies pour obtenir des anticorps qui se lient avec les peptides de récepteurs de lymphocytes T humains ou aux déterminants de conformation. L'invention décrit également les méthodes de préparation de ces anticorps à partir de fractions du plasma humain selon Cohn, par purification d'immunoaffinité, à l'aide de protéines de récepteur de lymphocytes T de recombinaison ou de peptides à région variable de récepteurs de lymphocytes T. La purification des anticorps de récepteurs de lymphocytes T à partir de mélanges d'anticorps humains ou animaux est effectuée suivant des procédures d'immunoaffinité qui font appel à des protéines de récepteurs de lymphocytes T humains de recombinaison. Les anticorps purifiés par immunoaffinité peuvent se fixer sur les récepteurs de lymphocytes T intacts liés à la membrane grâce à une sélection des cellules reposant sur la fluorescence et peuvent aussi inhiber la prolifération des lymphocytes T suite à une stimulation par le mithogène. Les anticorps polyclonaux humains purifiés par immunoaffinité peuvent inhiber l'activité lytique des cellules tueuses naturelles sur une ligne de lymphocyte T monoclonaux. Les préparations d'anticorps sont susceptibles d'être utilisées pour diagnostiquer, surveiller et soigner différents syndromes de maladies auto-immunes.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US34115794A | 1994-11-16 | 1994-11-16 | |
US08/341,157 | 1994-11-16 |
Publications (1)
Publication Number | Publication Date |
---|---|
CA2205138A1 true CA2205138A1 (fr) | 1996-05-23 |
Family
ID=23336462
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CA002205138A Abandoned CA2205138A1 (fr) | 1994-11-16 | 1995-11-15 | Anticorps humains pour les peptides recepteurs de lymphocytes t et leur methode de preparation |
Country Status (5)
Country | Link |
---|---|
EP (1) | EP0792294A1 (fr) |
JP (1) | JPH10509948A (fr) |
AU (1) | AU705010B2 (fr) |
CA (1) | CA2205138A1 (fr) |
WO (1) | WO1996015153A1 (fr) |
Families Citing this family (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB9904395D0 (en) * | 1999-02-25 | 1999-04-21 | Fluorescience Ltd | Protein assay |
US6972198B2 (en) | 1999-02-26 | 2005-12-06 | Cyclacel, Ltd. | Methods and compositions using protein binding partners |
AT410636B (de) * | 2001-03-23 | 2003-06-25 | Igeneon Krebs Immuntherapie | Verfahren zur herstellung eines impfstoffes |
US20050084967A1 (en) | 2002-06-28 | 2005-04-21 | Xcyte Therapies, Inc. | Compositions and methods for eliminating undesired subpopulations of T cells in patients with immunological defects related to autoimmunity and organ or hematopoietic stem cell transplantation |
EP1532983A1 (fr) | 2003-11-18 | 2005-05-25 | ZLB Bioplasma AG | Preparation d'immunoglobulines à stabilité élevée |
PL2531218T3 (pl) | 2010-02-04 | 2019-05-31 | Csl Behring Ag | Preparat immunoglobuliny |
EP2361636A1 (fr) | 2010-02-26 | 2011-08-31 | CSL Behring AG | Préparation d'immunoglobuline et système de stockage pour préparation d'immunoglobuline |
WO2013132347A2 (fr) * | 2012-03-06 | 2013-09-12 | Calpro As | Immunodosage elisa amélioré de la calprotectine |
JP6628719B2 (ja) | 2013-07-15 | 2020-01-15 | アメリカ合衆国 | 抗ヒトパピローマウイルス16 e6 t細胞受容体 |
AU2016319126A1 (en) | 2015-09-10 | 2018-04-19 | Affigen, Inc. | Sequencing-directed selection of tumor theranostics |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CA2018248A1 (fr) * | 1989-06-07 | 1990-12-07 | Clyde W. Shearman | Anticorps monoclonaux contre le recepteur alpha-beta de cellules t humaines, leur production et leur utilisation |
DE69120890T2 (de) * | 1990-05-03 | 1997-02-20 | Systemix Inc | Menschliches lymph-gewebe in einem wirt mit angegriffenem immunsystem |
-
1995
- 1995-11-15 CA CA002205138A patent/CA2205138A1/fr not_active Abandoned
- 1995-11-15 WO PCT/US1995/014869 patent/WO1996015153A1/fr not_active Application Discontinuation
- 1995-11-15 EP EP95939984A patent/EP0792294A1/fr not_active Ceased
- 1995-11-15 AU AU41611/96A patent/AU705010B2/en not_active Ceased
- 1995-11-15 JP JP8516317A patent/JPH10509948A/ja active Pending
Also Published As
Publication number | Publication date |
---|---|
EP0792294A1 (fr) | 1997-09-03 |
WO1996015153A1 (fr) | 1996-05-23 |
AU705010B2 (en) | 1999-05-13 |
AU4161196A (en) | 1996-06-06 |
JPH10509948A (ja) | 1998-09-29 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US5223426A (en) | Monoclonal antibodies reactive with defined regions of the t-cell antigen receptor | |
Chang et al. | Monoclonal antibodies specific for human IgE-producing B cells: a potential therapeutic for IgE-mediated allergic diseases | |
EP0307434B2 (fr) | Anticorps alteres | |
US5543144A (en) | Treating hypersensitivities with anti-IGE monoclonal antibodies which bind to IGE-expressing B cells but not basophils | |
US6790938B1 (en) | Anti-GPIIb/IIIa recombinant antibodies | |
AU724856B2 (en) | Anti-Fas ligand antibody and assay method using the anti-Fas ligand antibody | |
Wilson et al. | Monoclonal antibodies to the 140,000 mol wt glycoprotein of B lymphocyte membranes (CR2 receptor) initiates proliferation of B cells in vitro | |
WO1992004053A1 (fr) | Immunoglobulines homoconjuguees | |
JPH07126300A (ja) | ヒトのb細胞受容体複合体の特異抗原を認識するモノクローナル抗体 | |
JP2007045843A (ja) | 炎症性胃腸病の処置 | |
Gergely et al. | Chemical Analyses of Variable Regions of Heavy and Light Chains of Cold Agglutinins 1 | |
JPH01501201A (ja) | 抗体 | |
CA2205138A1 (fr) | Anticorps humains pour les peptides recepteurs de lymphocytes t et leur methode de preparation | |
Spurll et al. | A family of T-cell alloantigens linked to Igh-1 | |
US4882424A (en) | Activation antigen | |
Adib-Conquy et al. | Monoclonal IgG and IgM autoantibodies obtained after polyclonal activation, show reactivities similar to those of polyclonal natural autoantibodies | |
EP0511308B2 (fr) | Immunoglobuline chimerique pour recepteurs de cd4 | |
WO1992016563A1 (fr) | Anticorps monoclonaux reconnaissant l'antigene-3 associe a la fonction lymphocytaire | |
WO1994028023A1 (fr) | Proteine de membranes cellulaires exprimee par les thymocites du cortex humain, et son emploi | |
Lake et al. | Characterization of autoantibodies directed against T cell receptors | |
Elagib et al. | Characterization and VH sequences of human monoclonal anti-F (ab′) 2 autoantibodies from normals and Sjögren's syndrome patients | |
US7037496B2 (en) | Chimeric immunoglobulin for CD4 receptors | |
Tsukazaki et al. | A human monoclonal antibody to carbohydrate moiety of carcinoembryonic antigen | |
BUJANOWSKI | 0.1 Expression of FCE-Receptor II (CD23) and release of IgE-binding factors (IgE-BF) from lymphoblastoid cell line RPMI 8866 and | |
CA2005121A1 (fr) | Reactif d'anticorps monoclonaux avec des regions definies des recepteurs d'antigenes des cellules t |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FZDE | Dead |